Hai‐Bin Chen
Wenzhou Medical University(CN)Cancer Hospital of Chinese Academy of Medical Sciences(CN)
Publications by Year
Research Areas
Diabetes Treatment and Management, Pancreatic function and diabetes, Diabetes Management and Research, RNA modifications and cancer, Brain Metastases and Treatment
Most-Cited Works
- → Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma(2018)35 cited
- Cervical spinal canal narrowing and cervical neurological injuries.(2012)
- → SGLT2 inhibitors for the composite of cardiorenal outcome in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials(2022)15 cited
- → Indirect Comparison of SGLT2 Inhibitors in Patients with Established Heart Failure: Evidence Based on Bayesian Methods(2023)14 cited
- → Meta-Analysis of Randomized Controlled Trials Comparing Risk of Major Adverse Cardiac Events and Bleeding in Patients With Prasugrel Versus Clopidogrel(2015)13 cited
- → New progress in the treatment of diffuse midline glioma with H3K27M alteration(2024)8 cited
- → Single-cell transcriptomics reveals writers of RNA modification-mediated immune microenvironment and cardiac resident Macro-MYL2 macrophages in heart failure(2024)4 cited
- → The risk of all-cause death with dapagliflozin versus placebo: a systematic review and meta-analysis of phase III randomized controlled trials(2023)3 cited
- → Long Non-coding RNA CRNDE Promotes the Development of Glioma by Inducing Polarization of M2-Type Macrophages(2025)2 cited
- → The risk of bleeding and all-cause mortality with edoxaban versus vitamin K antagonists: A meta-analysis of phase III randomized controlled trials(2020)2 cited